In Vivo Evolution of X4 Human Immunodeficiency Virus Type 1 Variants in the Natural Course of Infection Coincides with Decreasing Sensitivity to CXCR4 Antagonists

Similar Items

• Increased Neutralization Sensitivity of Recently Emerged CXCR4-Using Human Immunodeficiency Virus Type 1 Strains Compared to Coexisting CCR5-Using Variants from the Same Patient
  od: Bunnik, Evelien M., i dr.
  Izdano: (2007)
• Cytopathic Effects of Non-Syncytium-Inducing and Syncytium-Inducing Human Immunodeficiency Virus Type 1 Variants on Different CD4(+)-T-Cell Subsets Are Determined Only by Coreceptor Expression
  od: Kwa, David, i dr.
  Izdano: (2001)
• Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic
  od: Euler, Zelda, i dr.
  Izdano: (2011)
• Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies
  od: van Gils, Marit J., i dr.
  Izdano: (2011)
• No Selection for CCR5 Coreceptor Usage during Parenteral Transmission of Macrophagetropic Syncytium-Inducing Human Immunodeficiency Virus Type 1
  od: Koning, Fransje A., i dr.
  Izdano: (2001)